Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+27.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$39.1B
AUM Growth
+$39.1B
(+17%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-2.74%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
264
Reduced
307
Closed
110
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$2.23B |
| 2 |
Otis Worldwide
OTIS
|
$211M |
| 3 |
Burlington
BURL
|
$200M |
| 4 |
AbbVie
ABBV
|
$199M |
| 5 |
Wayfair
W
|
$190M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$1.66B |
| 2 |
Lockheed Martin
LMT
|
$327M |
| 3 |
Johnson & Johnson
JNJ
|
$253M |
| 4 |
Pfizer
PFE
|
$153M |
| 5 |
Target
TGT
|
$148M |
Sector Composition
| 1 | Technology | 21.53% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Financials | 11.32% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KSU
426
DELISTED
Kansas City Southern
KSU
| $16.8M | 0.04% |
112,500
+2,400
| +2% | +$358K |
|
427
Novavax
NVAX
$1.23B
| $16.6M | 0.04% |
+199,600
| New | +$16.6M |
|
428
Healthpeak Properties
DOC
$12.5B
| $16.6M | 0.04% |
603,143
+44,000
| +8% | +$1.21M |
|
429
Ball Corp
BALL
$13.9B
| $16.5M | 0.04% |
237,797
+67,483
| +40% | +$4.69M |
|
430
Axsome Therapeutics
AXSM
$6.16B
| $16.5M | 0.04% |
200,000
+115,000
| +135% | +$9.46M |
|
431
Keysight
KEYS
$28.1B
| $16.4M | 0.04% |
162,825
-900
| -0.5% | -$90.7K |
|
|
VNTR
432
DELISTED
Venator Materials PLC
VNTR
| $16.4M | 0.04% |
9,156,202
| – | – |
|
433
Incyte
INCY
$16.8B
| $16.3M | 0.04% |
157,002
+14,300
| +10% | +$1.49M |
|
434
Domino's
DPZ
$15.9B
| $16.2M | 0.04% |
+43,973
| New | +$16.2M |
|
435
Comstock Resources
CRK
$4.8B
| $16.2M | 0.04% |
+3,700,000
| New | +$16.2M |
|
436
Advanced Drainage Systems
WMS
$11B
| $16.1M | 0.04% |
326,670
+226,670
| +227% | +$11.2M |
|
437
Valero Energy
VLO
$47.9B
| $16.1M | 0.04% |
273,300
-208,000
| -43% | -$12.2M |
|
438
Abeona Therapeutics
ABEO
$351M
| $16M | 0.04% |
5,500,000
| – | – |
|
|
MRNS
439
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $16M | 0.04% |
6,300,000
+1,500,000
| +31% | +$3.81M |
|
440
Boston Properties
BXP
$11.5B
| $15.8M | 0.04% |
174,918
-15,600
| -8% | -$1.41M |
|
441
International Paper
IP
$26B
| $15.8M | 0.04% |
447,892
-7,900
| -2% | -$278K |
|
442
RingCentral
RNG
$2.74B
| $15.7M | 0.04% |
+55,000
| New | +$15.7M |
|
443
Cenovus Energy
CVE
$30.5B
| $15.6M | 0.04% |
3,350,000
+3,100,000
| +1,240% | +$14.5M |
|
444
Broadridge
BR
$29.5B
| $15.6M | 0.04% |
+123,900
| New | +$15.6M |
|
|
HES
445
DELISTED
Hess
HES
| $15.6M | 0.04% |
+301,700
| New | +$15.6M |
|
|
CHMA
446
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.6M | 0.04% |
2,900,000
| – | – |
|
447
Nasdaq
NDAQ
$53.7B
| $15.6M | 0.04% |
130,580
+2,600
| +2% | +$311K |
|
448
Syndax Pharmaceuticals
SNDX
$1.39B
| $15.6M | 0.04% |
1,050,000
+50,000
| +5% | +$741K |
|
449
Oneok
OKE
$47B
| $15.5M | 0.04% |
466,700
-9,900
| -2% | -$329K |
|
|
AMTD
450
DELISTED
TD Ameritrade Holding Corp
AMTD
| $15.5M | 0.04% |
425,500
-1,000,000
| -70% | -$36.4M |
|